Societal Perspectives and Patient/Public Involvement in Direct-Acting Antiviral Agent Coverage of Hepatitis C Treatment in the United States

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1814-1815. doi: 10.1016/j.cgh.2017.06.009. Epub 2017 Jun 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents*
  • Genotype
  • Hepacivirus
  • Hepatitis C*
  • Hepatitis C, Chronic*
  • Humans
  • United States

Substances

  • Antiviral Agents